Israel Englander Igm Biosciences, Inc. Call Options Transaction History
Millennium Management LLC
- $192 Billion
- Q4 2024
Call Options
2 transactions
Others Institutions Holding IGMS
# of Institutions
85Shares Held
19.8MCall Options Held
75KPut Options Held
35.9K-
Baker Bros. Advisors LP New York, NY4.09MShares$5.85 Million0.28% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.57MShares$5.1 Million0.0% of portfolio
-
Siren, L.L.C. New York, NY3.33MShares$4.76 Million0.9% of portfolio
-
Redmile Group, LLC San Francisco, CA2.95MShares$4.22 Million1.41% of portfolio
-
Goldman Sachs Group Inc New York, NY978KShares$1.4 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $41.4M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...